Oleuropein: a viable therapeutic option for malaria and cancer

Area of Science:

• Pharmacology
• Immunology
• Oncology
• Infectious Diseases

Background:

• Oleuropein (OLP) is a natural compound with demonstrated therapeutic potential.
• Plasmodium falciparum infection and various cancers represent significant global health challenges.
• Understanding OLP's molecular mechanisms is crucial for developing novel treatments.

Purpose of the Study:

• To investigate the therapeutic potential of Oleuropein (OLP) against Plasmodium falciparum infection and cancer.
• To elucidate the molecular pathways targeted by OLP, including the PI3K-Akt1 signaling pathway and the cell death/autophagy axis.
• To evaluate the immunomodulatory effects of OLP relevant to cancer therapy.

Main Methods:

• In vitro and in vivo studies were conducted to assess OLP's antimalarial and anticancer activities.
• The modulation of the phosphoinositide 3-kinase (PI3K)-Akt1 signaling pathway was analyzed.
• The impact of OLP on the cell death/autophagy axis was investigated.
• Immune cell populations, specifically T helper 17 and regulatory T cells, were assessed in the context of anti-cancer effects.
• Humanized immune system mouse models were utilized for validation.

Main Results:

• Oleuropein (OLP) demonstrated efficacy in combating Plasmodium falciparum infection and exhibited anti-breast-cancer properties.
• OLP modulates the PI3K-Akt1 signaling pathway, influencing inflammation and immune homeostasis.
• The compound affects the cell death/autophagy axis and enhances the antimalarial efficacy of artemisinin.
• The anti-cancer effect of OLP is linked to the regulation of T helper 17 and regulatory T cell balance.
• Validation of OLP's antimalarial, autophagy, and anticancer activities was performed in humanized mouse models.

Conclusions:

• Oleuropein (OLP) presents a promising therapeutic candidate for both malaria and cancer.
• OLP exerts its effects through modulation of key signaling pathways and immune cell populations.
• Further research and validation in preclinical models support the clinical potential of OLP.